ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Evaluation Of Typical Renal Transplant Infections In Simultaneous Heart-kidney Transplant Recipients

E. J. Henricksen1, U. Wang1, R. Lee1, R. Imai1, A. Puing2, A. Couture2, A. Multani3, Y. Moayedi4, C. Lenihan5, K. K. Khush6, J. J. Teuteberg5

1Pharmacy, Stanford Healthcare, Stanford, CA, 2Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, 3Infectious Diseases, UCLA, Los Angeles, CA, 4Cardiology, University Health Network, Toronto, ON, Canada, 5Department of Medicine, Stanford University, Stanford, CA, 6Medicine, Stanford University, Stanford, CA

Meeting: 2020 American Transplant Congress

Abstract number: C-184

Keywords: Bacterial infection, Heart transplant patients, Infection, Kidney transplantation

Session Information

Session Name: Poster Session C: All Infections (Excluding Kidney & Viral Hepatitis)

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Simultaneous heart-kidney transplant (SHKT) is an increasingly utilized treatment for patients with end stage heart failure and advanced kidney disease. Data regarding infectious complications in this population are limited. The purpose of this study was to examine the incidence of kidney transplant/urinary tract infection after SHKT.

*Methods: This was a retrospective analysis of adult SHKT recipients at a single institution between January 2008 and September 2019. All patients received induction with either antithymocyte globulin or daclizumab, and Pneumocystis jirovecii (PJP) prophylaxis with either trimethoprim-sulfamethoxazole (TMP-SMX) or atovaquone was given for 1 year post SHKT. Kidney transplant /urinary tract infections were categorized as 1) urinary tract infection (UTI), 2) BK polyomavirus viremia (BKVV) and 3) urinary adenovirus infection. UTI was defined as a positive urine culture with > 105 cfu/mL warranting treatment. BKV viremia was defined as a positive plasma BKV PCR assay and urinary adenovirus infection was defined as a positive urine adenovirus PCR assay. Primary outcome was incidence of UTI while on PJP prophylaxis. Descriptive statistics were performed on incidence of UTIs, BKV and adenovirus.

*Results: Of the 32 SHKT recipients, 13 (41%) developed UTI, 7 (22%) were positive for BKVV and 0 (0%) were positive for adenovirus. All UTIs were bacterial, with 10 (77%) occurring while receiving PJP prophylaxis. There was no significant difference in the proportion of patients with UTIs, when comparing agents for PJP prophylaxis (p=0.14) (Figure). Median time to initial UTI was 116 days (59-363). 4 (31%) patients developed 2 or more UTIs. There were no significant differences in baseline characteristics between groups.

*Conclusions: A significant number of SHKT recipients develop bacterial UTIs and BKVV post-transplant, with the majority occurring within the first year. We found no urinary adenovirus infections in our cohort. We found no significant difference in UTIs between PJP prophylaxis regimens, although this study was likely underpowered to assess this outcome. Heart transplant providers must remain cognizant of potential renal infections when caring for SHKT recipients.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Henricksen EJ, Wang U, Lee R, Imai R, Puing A, Couture A, Multani A, Moayedi Y, Lenihan C, Khush KK, Teuteberg JJ. Evaluation Of Typical Renal Transplant Infections In Simultaneous Heart-kidney Transplant Recipients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/evaluation-of-typical-renal-transplant-infections-in-simultaneous-heart-kidney-transplant-recipients/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences